164 related articles for article (PubMed ID: 28279563)
1. A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.
Probst P; Grigg JB; Wang M; Muñoz E; Loo YM; Ireton RC; Gale M; Iadonato SP; Bedard KM
Vaccine; 2017 Apr; 35(15):1964-1971. PubMed ID: 28279563
[TBL] [Abstract][Full Text] [Related]
2. A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
Hemann EA; Knoll ML; Wilkins CR; Subra C; Green R; García-Sastre A; Thomas PG; Trautmann L; Ireton RC; Loo YM; Gale M
J Immunol; 2023 May; 210(9):1247-1256. PubMed ID: 36939421
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
[TBL] [Abstract][Full Text] [Related]
4. Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.
Kulkarni RR; Rasheed MA; Bhaumik SK; Ranjan P; Cao W; Davis C; Marisetti K; Thomas S; Gangappa S; Sambhara S; Murali-Krishna K
J Virol; 2014 Dec; 88(24):13990-4001. PubMed ID: 25253340
[TBL] [Abstract][Full Text] [Related]
5. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
6. Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus.
Wong PT; Goff PH; Sun RJ; Ruge MJ; Ermler ME; Sebring A; O'Konek JJ; Landers JJ; Janczak KW; Sun W; Baker JR
Mol Pharm; 2021 Feb; 18(2):679-698. PubMed ID: 32491861
[TBL] [Abstract][Full Text] [Related]
7. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
[TBL] [Abstract][Full Text] [Related]
8. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
[TBL] [Abstract][Full Text] [Related]
9. Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.
Russell RF; McDonald JU; Lambert L; Tregoning JS
J Virol; 2016 May; 90(9):4735-4744. PubMed ID: 26912628
[TBL] [Abstract][Full Text] [Related]
10. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
11. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
Even-Or O; Samira S; Rochlin E; Balasingam S; Mann AJ; Lambkin-Williams R; Spira J; Goldwaser I; Ellis R; Barenholz Y
Vaccine; 2010 Sep; 28(39):6527-41. PubMed ID: 20412874
[TBL] [Abstract][Full Text] [Related]
13. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
Baldwin SL; Hsu FC; Van Hoeven N; Gage E; Granger B; Guderian JA; Larsen SE; Lorenzo EC; Haynes L; Reed SG; Coler RN
Front Immunol; 2018; 9():295. PubMed ID: 29515589
[TBL] [Abstract][Full Text] [Related]
14. The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4
Jain S; George PJ; Deng W; Koussa J; Parkhouse K; Hensley SE; Jiang J; Lu J; Liu Z; Wei J; Zhan B; Bottazzi ME; Shen H; Lustigman S
Vaccine; 2018 Jun; 36(25):3650-3665. PubMed ID: 29764680
[TBL] [Abstract][Full Text] [Related]
15. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
[TBL] [Abstract][Full Text] [Related]
16. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets.
Han HJ; Song MS; Park SJ; Byun HY; Robles NJC; Ha SH; Choi YK
J Microbiol; 2019 Feb; 57(2):163-169. PubMed ID: 30706345
[TBL] [Abstract][Full Text] [Related]
18. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
Luo M; Qu X; Pan R; Zhu D; Zhang Y; Wu J; Pan Z
Vaccine; 2011 Mar; 29(14):2561-7. PubMed ID: 21303708
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness.
Jeong JH; Kim EH; Lloren KKS; Kwon JJ; Kwon HI; Ahn SJ; Kim YI; Choi WS; Si YJ; Lee OJ; Han HJ; Baek YH; Song MS; Choi YK; Kim CJ
Vaccine; 2019 Jan; 37(3):484-493. PubMed ID: 30502069
[TBL] [Abstract][Full Text] [Related]
20. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
Wang SH; Smith D; Cao Z; Chen J; Acosta H; Chichester JA; Yusibov V; Streatfield SJ; Fattom A; Baker JR
Vaccine; 2019 Mar; 37(12):1591-1600. PubMed ID: 30795941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
